Xia Liang, Zheng Rongshou, Xu Yanjun, Xu Xiaojun, Zhang Siwei, Zeng Hongmei, Lin Lifeng, Chen Wanqing
Institute of Non-communicable Disease Control and Prevention, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, China.
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100021, China.
Chin J Cancer Res. 2019 Feb;31(1):135-143. doi: 10.21147/j.issn.1000-9604.2019.01.08.
In this study, we aimed to estimate the updated incidence and mortality of primary bone cancers based on population-based cancer registration data in 2014, collected by the National Central Cancer Registry of China (NCCRC).
In 2017, 339 registries' data were qualified based on data quality criteria set down by the NCCRC. Cases of primary bone cancers were retrieved from the national database. We estimated numbers of primary bone cancer cases and deaths in China using age-specific rates and corresponding national population stratified by area, sex, age-group (0, 1-4, 5-9, 10-14, …, 85+). Chinese standard population in 2000 and Segi's World population were applied for the calculation of age-standardized incidence and mortality rates.
In 2014, 24,000 primary bone cancer cases and 17,200 deaths attributable to primary bone cancers were estimated to have occurred in China. The crude incidence rate of primary bone cancers was 1.76/100,000, with age-standardized incidence rate by Chinese standard population (ASIRC) and by World standard population (ASIRW) being 1.35/100,000 and 1.32/100,000, respectively. The crude mortality rate of primary bone cancers was 1.26/100,000, with age-standardized mortality rate by Chinese standard population (ASMRC) and by World standard population (ASMRW) being 0.88/100,000 and 0.86/100,000, respectively. Age-specific incidence curve was bimodally distributed with age, with the first peak occurring in the second decade of the life and the second peak in the elderly. Males had higher crude and age-standardized rates for both incidence and mortality compared with females. Both crude and age-standardized incidence rates were higher in rural areas than in urban areas, so were the crude and age-standardized mortality rates.
This population-based study presents the most recently available estimates on primary bone cancers in China, revealing that the males are 1.34 times as much as females suffering from primary bone cancers and the adolescents in puberty and the elderly are predominantly affected groups by these cancers. High-quality cancer registration data are a prerequisite for undertaking further study for gaining insight into the causes and risk factors for primary bone cancers in China.
在本研究中,我们旨在根据中国国家癌症中心(NCCRC)收集的2014年基于人群的癌症登记数据,估算原发性骨癌的最新发病率和死亡率。
2017年,根据NCCRC制定的数据质量标准,339个登记处的数据符合要求。从国家数据库中检索原发性骨癌病例。我们使用特定年龄发病率和按地区、性别、年龄组(0、1 - 4、5 - 9、10 - 14、…、85岁及以上)分层的相应全国人口,估算中国原发性骨癌病例数和死亡数。应用2000年中国标准人口和Segi世界人口计算年龄标准化发病率和死亡率。
2014年,中国估计发生了24,000例原发性骨癌病例,17,200例归因于原发性骨癌的死亡。原发性骨癌的粗发病率为1.76/10万,按中国标准人口计算的年龄标准化发病率(ASIRC)和按世界标准人口计算的年龄标准化发病率(ASIRW)分别为1.35/10万和1.32/10万。原发性骨癌的粗死亡率为1.26/10万,按中国标准人口计算的年龄标准化死亡率(ASMRC)和按世界标准人口计算的年龄标准化死亡率(ASMRW)分别为0.88/10万和0.86/10万。特定年龄发病率曲线随年龄呈双峰分布,第一个峰值出现在生命的第二个十年,第二个峰值出现在老年人中。男性的粗发病率和年龄标准化发病率及死亡率均高于女性。农村地区的粗发病率和年龄标准化发病率均高于城市地区,粗死亡率和年龄标准化死亡率也是如此。
这项基于人群的研究提供了中国原发性骨癌的最新可用估计,表明男性患原发性骨癌的人数是女性的1.34倍,青春期青少年和老年人是这些癌症的主要受影响群体。高质量的癌症登记数据是进一步研究以深入了解中国原发性骨癌病因和危险因素的先决条件。